Member Info for Richob

Been reading up on this.

You can't sell into the EU without an authorised representative, so just one example of what has to go on in the background.

Strange time to sell knowing this is now in place but each to their own approach of course.

Very much looking forward to announced sales and AVA6000 updates.

Onwards Avacta.

Just looked up what they do:

Advena Ltd. was founded in 1996 and provides cost-effective regulatory affairs consulting services to small and medium- sized medical device manufacturers and distributors seeking to import their medical devices into the European Union.

Not sure why you would need them unless you were selling into the EU.

Onwards Avacta.

A pharmaceutical company has known recruitment for a cancer trial in a UK hospital. As PL75 rightly pointed out, all the very best to those being recruited.

A further five UK hospitals are to be involved in additional cancer trials.

The same company is selling a LFT for covid that detects variants and is highly specific.

Is it Roche, market cap £300bn?
Is it J&J, market cap £400bn?
Is it Pfizer, market cap £310bn?

No, it is Avacta, market cap £327 million.

I agree that the company should be announcing both of the above achievements but either they think they already have or are awaiting announcing even bigger achievements.

Onwards Avacta.

Worth sending to anyone you may know that unfortunately has pancreatic cancer.

I think Bioserv are just the UK arm of Calibre, who operate out of six countries and cover 100 countries for delivery.

Don't think all production is going to Bioserv in the UK.

Onwards Avacta.

Thanks, Wildstar. Haven't seen it before even though I look. Must be my age !

Onwards Avacta.

Think this is new ....

“What drives us all at Avacta is the opportunity to realise the incredible potential of the Affimer and pre|CISION platforms to create new tools for life sciences and, in our own drug development programmes, to make a measurable difference to patients lives through clinically superior cancer immunotherapies.”

Alastair Smith, Chief Executive Officer, Avacta

Sums up two key reasons for being here.

Onwards Avacta.

That would work, Neutronic and be a boost to the daily volume and the sp.

Onwards Avacta.

The tin of beans I ordered hasn't turned up and Heinz haven't issued an RNS saying how many tins of beans they have sold this week.

Should I sell my Heinz shares?

Not really a question, just putting some recent comments into perspective.

Onwards Avacta.

... in all of the world.

Bill Gates links up with Mologic. He and Soros then buy it as philanthropists to help the third world.

Mologic have a collaboration agreement with Avacta. We have worked on LFTs together and Mologic are well aware of affimers.

Doctor Eliot Foster, chairman of Avacta, has worked with The Bill and Melinda Gates Foundation.

Agree with Ophidian, Bill Gates is aware of Avacta.

Pass me my gin.

Onwards Avacta.

... from the 16th of August, said Boris.

This was in answer to a question asked about how isolating was affecting many businesses.

Time for Affidx I would have thought.

Onwards Avacta.

Whilst Bill Gates is a philanthropist and George Soros might also be a philanthropist, they are also shrewd enough to buy into companies that Mologic would be using you would think.

Can't see anything not good about this.

Onwards Avacta.

I still think that key requirements for an uplift in sp are in place.

1. Going the EU route versus the corrupt UK
2. ISO accreditation
3. Known manufacturing capability.

And that is just the LFT.

I guess we all have a view and mine is hold and buy but I understand the current frustration for some.

All the best.

Onwards Avacta.

PS For those posting about having a brand, two are registered, AffiDX and AffiRX. The DX is Latin for diagnostics and the RD is Latin for therapy.

The intellectual property is being proven.

Onwards Avacta.

I see that the "discussion board roamers" are all arriving for reasons best known to them. The only reason I know is that they wish to buy in low.

Worth clicking on their name to check their previous posts to see what they are trying to do.

This morning's initial sp only changed when there were no trades for the first three minutes. The MMs then "did their job" and dropped the price to encourage trade volume.

They've actually just done it again in a brief lull, which has attracted the board roamers.

Nothing has changed here, we still have three top quality Intellectual Properties, two of which are ready to produce the goods.

Very little to be seen on level two above 147p for those interested.

Onwards Avacta.

The recent drop in the sp has clearly been disappointing for all holders.

During these times it is, perhaps, easy to forget that this company is based on three intellectual properties:

Affimer
Precision
FAP

The first IP is proven given that numerous companies rent it and agree to both up front payments and royalties. This is a growing aspect of the company.

The second IP is entering clinical trials, which will concern much larger companies that currently receive incredible income from cancer drugs. The "buy out" aspect comes from here.

The third IP is yet to enter the fray but far exceeds the other two. Poirot knows more about this than anybody outside of the company.

Sensible shareholders would logically base their investment in a threefold way but the majority here appear to have based their investment on just one aspect of the first IP. Even some non-investors are commenting on this aspect for some reason known best to them.

Well, the LFT they are concerned about just happens to detect all variants. Enough said for me, or we could even talk about S&S but that might be beyond requirements as sales will undoubtedly come in this worldwide pandemic.

Just my thoughts. Awaiting a few green boxes but have never bothered about them of course.

Onwards Avacta.

You mean we do cancer stuff as well !

Blimey.

Onwards Avacta.

Having just read that "nothing is happening", I have come to the conclusion that I am living in an alternate universe where:

Six UK hospitals are not recruiting for AVA6000 trials
Avacta haven't jointly sponsored research into the cancer death star
Our LFT doesn't detect all known variants
I can't order an Avacta LFT
No discussions are happening to buy the Avacta LFT anywhere in Europe
There is no interest in the Avacta LFT in APAC countries

This must all be linked to the UFO revelations in the press is all I can conclude.

Onwards Avacta.

I think they meant 280p now with further inflection points:

"Ample news flow is expected over 18-24 months, providing multiple value-inflection points. Our valuation is £710m, equivalent to 280p/share."

280p is where we were before UK and EU validation and obviously before confirmation that the test covers the delta variant.

It's coming.

Interesting question about "professional use", supervised, or self testing.

It would also be good to understand just what training is required to be called "professional" as we had to take three tests each, done by ourselves, to go to Portugal a month or so ago.

I've never seen a job advert for a professional covid tester and given the clamour now from schools to change the "bubble approach", I think "supervised" is a given on its way and that would be the teacher.

Can't be long now for order number one, then order number two .....

Onwards Avacta.

Whilst "all resolutions passed" is the usual for an AGM, the fact that there was a protective resolution passed may be significant.

We have owned the IPs for some time but just as we take AVA6000 into trials and the LFT comes on sale, the likelihood of a hostile takeover increases.

Why fight it? Well, hostile takeovers tend to be for less than a company believes it is worth and no doubt Avacta have a "fair value" placed on the IPs,
as they should.

Of course, it may not mean anything but the timing is interesting.

Onwards Avacta.